James Lynch, MD

Articles by James Lynch, MD

Improving the Therapeutic Ratio in Hodgkin Lymphoma Through the Use of Proton Therapy

ByBradford S. Hoppe, MD, MPH,Stella Flampouri, PhD,James Lynch, MD,William Slayton, MD,Robert Zaiden, MD,Nancy Price Mendenhall, MD

May 15th 2012

This review addresses the rationale and evidence for-and the challenges, cost implications, and future development of-proton therapy as an important part of the treatment strategy in Hodgkin lymphoma.

Latest Updated Articles

Improving the Therapeutic Ratio in Hodgkin Lymphoma Through the Use of Proton Therapy
May 15th 2012

Trending on CancerNetwork

124 Real-World Progression-Free Survival 2 and Tumor Response of CDK4/6is + Aromatase Inhibitor in Patients With HR+/HER2– Metastatic Breast Cancer

Zenocutuzumab Earns FDA National Priority Voucher in Cholangiocarcinoma

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

123 Real-World Patient and Caregiver Experiences With Breast Cancer (BC) Risk of Recurrence (ROR) in the US: Results of an Online Survey and Social Media Analysis